These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38842201)

  • 1. RBM15-Mediated N6-Methyl Adenosine (m6A) Modification of EZH2 Drives the Epithelial-Mesenchymal Transition of Cervical Cancer.
    Wang R; Tan W
    Crit Rev Eukaryot Gene Expr; 2024; 34(5):15-29. PubMed ID: 38842201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.
    Chen WW; Qi JW; Hang Y; Wu JX; Zhou XX; Chen JZ; Wang J; Wang HH
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4263-4270. PubMed ID: 32373962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
    Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
    Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-Methyladenosine modified circ-NAB1 modulates cell cycle and epithelial-mesenchymal transition via CDKN3 in endometrial cancer.
    Zhang J; Zhang Y; Zhang J
    Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):161-169. PubMed ID: 38814199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The m6A methyltransferase RBM15 affects tumor cell stemness and progression of cervical cancer by regulating the stability of lncRNA HEIH.
    Quan Y; Zhou M; Li J; Yang Y; Guo J; Tang T; Liu P
    Exp Cell Res; 2024 Mar; 436(2):113924. PubMed ID: 38280435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
    Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
    Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.
    Tian Q; Huang J; Zhang Q; Zhao J
    Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13864. PubMed ID: 38679464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.
    Zhang Z; Mei Y; Hou M
    Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBM15 m
    Song Y; Wu Q
    Environ Toxicol; 2023 Sep; 38(9):2155-2164. PubMed ID: 37334762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer.
    Zhang C; Gu L; Xiao J; Jin F
    BMC Cancer; 2023 Jul; 23(1):684. PubMed ID: 37474926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2-Mediated microRNA-139-5p Regulates Epithelial-Mesenchymal Transition and Lymph Node Metastasis of Pancreatic Cancer.
    Ma J; Zhang J; Weng YC; Wang JC
    Mol Cells; 2018 Sep; 41(9):868-880. PubMed ID: 30304920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation of miR-138 regulates cell proliferation and EMT in cervical cancer by targeting EZH2.
    Chen R; Gan Q; Zhao S; Zhang D; Wang S; Yao L; Yuan M; Cheng J
    BMC Cancer; 2022 May; 22(1):488. PubMed ID: 35505294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.
    Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4328-4336. PubMed ID: 32373970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRABP2 accelerates epithelial mesenchymal transition in serous ovarian cancer cells by promoting TRIM16 methylation via upregulating EZH2 expression.
    Xie T; Tan M; Gao Y; Yang H
    Environ Toxicol; 2022 Aug; 37(8):1957-1967. PubMed ID: 35442568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in Colorectal Carcinoma Cells.
    Jacksi M; Schad E; Tantos A
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
    Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
    J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOP2 facilitates EZH2-mediated epithelial-mesenchymal transition by enhancing EZH2 mRNA stability via m5C methylation in lung cancer progression.
    Yang Y; Fan H; Liu H; Lou X; Xiao N; Zhang C; Chen H; Chen S; Gu H; Liu H; Wan J
    Cell Death Dis; 2024 Jul; 15(7):506. PubMed ID: 39013911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV E6 promotes cell proliferation of cervical cancer cell by accelerating accumulation of RBM15 dependently of autophagy inhibition.
    Nie G; Tang B; Lv M; Li D; Li T; Ou R; Xu Y; Wen J
    Cell Biol Int; 2023 Aug; 47(8):1327-1343. PubMed ID: 37191290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.